A Study of TL-925 Ophthalmic Emulsion as a Treatment for Dry Eye Disease

NCT06225973 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

880

Enrollment

INDUSTRY

Sponsor class

Conditions

Dry Eye Disease

Interventions

DRUG: TL-925
OTHER: Placebo

Sponsor

Telios Pharma, Inc.